Published
Psilocybin-unterstützte Psychotherapie reduziert Ängste und Depressionen
No abstract availability was recorded for this entry.
Bibliographic context
- Journal
- InFo Hämatologie + Onkologie
- Date
- 2024-11-01
- Source
- OpenAlex
- PubMed
- Unavailable
Derived topics and classifications
These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVESThe International Journal of Neuropsychopharmacology · 2025-08-01Psychedelics’ Use as Medicine Hits Significant RoadblockPsychiatric News · 2024-06-12Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-07Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-13Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental HealthAdvances in Research · 2023-01-30Hallucinogen chemistry guides antidepressant drug discoveryC&EN Global Enterprise · 2022-02-06Maddening Therapies: How Hallucinogens Morphed into Novel TreatmentsCurrent psychiatry · 2017-01-01Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain DurabilityTherapeutics · 2026-10-19